Age-related nuclear cataracts are associated with progressive post-synthetic modifications of crystallins from various physical chemical and metabolic insults, of which oxidative stress is a major factor. The latter is normally suppressed by high concentrations of glutathione (GSH), which however are very low in the nucleus of the old lens. Here we generated a mouse model of oxidant stress by knocking out glutathione synthesis in the mouse in the hope of recapitulating some of the changes observed in human age-related nuclear cataract (ARNC). A floxed Gclc mouse was generated and crossed with a transgenic mouse expressing Cre in the lens to generate the LEGSKO mouse in which de novo GSH synthesis was completely abolished in the lens. Lens GSH levels were reduced up to 60% in homozygous LEGSKO mice, and a decreasing GSH gradient was noticed from cortical to nuclear region at 4 months of age. Oxidation of crystallin methionine and sulfhydryls into sulfoxides was dramatically increased, but methylglyoxal hydroimidazolones levels that are GSH/glyoxalase dependent were surprisingly normal. Homozygous LEGSKO mice developed nuclear opacities starting at 4 months that progressed into severe nuclear cataract by 9 months. We conclude that the LEGSKO mouse lens mimics several features of human ARNC and is thus expected to be a useful model for the development of anti-cataract agents.
Citation: Fan X, Liu X, Hao S, Wang B, Robinson ML, Monnier VM (2012) The LEGSKO Mouse: A Mouse Model of Age-Related Nuclear Cataract Based on Genetic Suppression of Lens Glutathione Synthesis. PLoS ONE 7(11): e50832. https://doi.org/10.1371/journal.pone.0050832
Editor: K. Krishna Sharma, University of Missouri-Columbia, United States of America
Received: August 16, 2012; Accepted: October 25, 2012; Published: November 30, 2012
Copyright: © 2012 Fan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants EY-07099 to VMM, the Vilma and Robert R. Kohn Biology of Aging Research Fund, and grant P30EY-11373 to the Visual Sciences Research Center at Case Western Reserve University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Cataract is a leading cause of blindness, accounting for 50% of blindness worldwide . The cumulative incidence of cataract is strongly age-related and ranges from 2% at ages 45–54 years to 45% at ages 75–85 , with nuclear cataracts accounting for 30% of all age-related cataracts . Surgical removal of the cataractous lens remains the only therapy, yet the National Eye Institute has estimated that a ten-year delay in the onset of cataract would result in a 50% reduction in the prevalence of cataract . Both lens nuclear opacity and nuclear cataract surgery are associated with increased mortality according to the Beaver Dam Eye Study  and the Age-Related Eye Disease Study (AREDS) . Thus, understanding the pathogenesis of age-related nuclear cataracts remains an important goal of vision research that may also provide clues on broader mechanisms of aging.
Age-related cataract is strongly related to the accumulation of damage to its long-lived proteins, the crystallins. Major age-related lens protein modifications include deamidation, deamination, racemization, accumulation of truncation products, accumulation of UV active, fluorescent, and non-UV active protein adducts and crosslinks from glycation, ascorbylation and lipoxidation reactions . Collectively, these modifications contribute toward decreasing protein stability, partly by impairing the chaperone function of α-crystallins, the levels of which decrease with age due to insolubilization . Overall, the aging human lens is constantly exposed to chemical and physical stresses. However, while oxidative damage is subdued during normal aging, it is a major cause or consequence of nuclear cataracts, the most common types of age-related cataracts, whereby the loss of glutathione (GSH) and formation of disulfides are considered to be the key factors in oxidative stress and nuclear cataractogenesis .
To protect from oxidation the lens has evolved as an anaerobic system with millimolar concentrations of both glutathione (GSH) and ascorbic acid. However, both protective systems are impaired during aging whereby GSH level significantly declines in the lens nucleus , . This is in part attributed to lowered γ-glutamyl-cysteine ligase (Gcl) activity  and a barrier to GSH diffusion toward the nucleus . As a result ascorbic acid is increasingly oxidized throughout life leading to accelerated accumulation of crystallin-bound advanced glycation end products (AGEs) that contribute to cataractogenesis , , . Concomitantly, increased protein residue oxidation is observed, as reflected by the formation of methionine sulfoxide, protein disulfides, kynurenine, and o-tyrosine from methionine, cysteine, tryptophan and phenylalanine, respectively , , .
In spite of considerable progress in the field, it has been extraordinarily difficult to study the relationship between the protein modifications and carbonyl stress or oxidant stress due to lack of appropriate animal models. One recent model of carbonyl stress developed by us successfully mimics the carbonyl stress component of the aging lens . However, while several models illustrate the role of glutathione for sulfhydryl homeostasis, its role for lens transparency during aging has not been unequivocally established. Indeed most chemically or genetic induced models of disrupted GSH homeostasis only produced opacity in pups or very young animals, with uncertainties as to whether the observed lenticular changes were due to developmental abnormalities or chemical toxicity via pathways unrelated to oxidation itself. For this reason, we set out to genetically lower lenticular glutathione levels specifically in the lens (since the systemic knockout is lethal ) by disrupting the catalytic subunit of γ-glutamyl- cysteine ligase (Gclc) using a conditional Cre/LoxP approach. The predicted slow decline in glutathione levels using this approach is hypothesized to mimic the processes underlying the oxidative arm of human ARNC. Below we present the genetic, biochemical and biological phenotypes of resulting from the loss of Gclc function in the lens of the Lens Glutathione Synthesis KnockOut (LEGSKO) mouse.
Conditional Deletion of Gclc Impairs Lens GSH Synthesis
In order to specifically delete Gclc from the lens, we crossed the Gclcfl/fl mice with MRL10-Cre mice  that express Cre recombinase in lens epithelia and fibers to ultimately generate mice homozygous for the conditional allele and hemizygous for MLR10 transgene. These mice Gclc−/−/MRL-10+/− are deficient for Gclc specifically in the lens and are, herein named homozygous lens GSH knockout mice (HOM-LEGSKO). Similarly, the Gclcfl/+/MRL-10+/− mice were named heterozygous lens GSH knockout mice (HET-LEGSKO) and should exhibit reduced Gclc levels in the lens. No lens abnormalities have been reported for mice that are hemizygous or homozygous for the MRL10-cre transgene in the absence of floxed alleles , and therefore phenotypes manifested in LEGSKO mice were contributed by Gclc deficiency alone. The LEGSKO mice were continuously crossbred with Gclcfl/fl mice (C57BL/6) to convert the genomic background towards C57BL/6. All the data provided in this paper are based on B6/FVB mixed background at third generation bred mice. The same breeding pattern and age matched control mice were used as wild type controls (Gclcfl/fl).
LEGSKO mice exhibited reduced expression of Gclc transcripts and protein. HOM-LEGSKO lenses exhibited nearly undetectable levels of Gclc mRNA by real-time PCR, and Gclc transcripts were reduced nearly 50% in HET-LEGSKO lenses compared to wild type lenses (Fig. 1A). The levels of Gclc mRNA and protein were indistinguishable between Gclcfl/fl lenses (without MLR10 transgene) and lenses of wild-type mice (data not shown). The lens Gclc protein expression was completely abolished in HOM-LEGSKO lenses compared to wild type lenses based on western-blot analysis (Fig.1B). This was also confirmed by immunohistochemistry analysis using monoclonal Gclc antibody (data not shown). The deletion of Gclc gene had no impact on glutamate-cysteine ligase, modifier subunit (Gclm) protein level (Fig. 1B). Most importantly, the Gclc activity determined by monobromobimane derivatization and HPLC analysis with fluorescence detection clearly demonstrated no detectable activity in HOM-LEGSKO lenses (Fig.1C). Interestingly, however, there was only 20% reduction of Gclc activity in HET-LEGSKO lenses compared to wild type lenses. HET-LEGSKO lenses had a ∼50% reduction of Gclc mRNA (Fig.1A) and 25% lower protein expression (Fig. 1B). The most intriguing finding was that HET-LEGSKO mice lenses maintained quasi-normal GSH level (reduced <10%), while HOM-LEGSKO GSH levels were more than 60% reduced compared to wild type lenses at 3months of age (Fig.1D). These results indicate that compensatory mechanisms might be involved in lens GSH homeostasis, most likely via transporter(s) systems as suggested by others . Moreover, analysis of cortical and nuclear GSH content in the HOM-LEGSKO lenses at 5 months of age (Table 1) revealed a GSH gradient from cortex to nucleus, with over 75% decreased in GSH in the nuclear vs. only a 50% decrease of GSH within the cortical region.
3mos old LEGSKO mouse lens (without cataract) total RNA was extracted and Gclc mRNA was determined by real-time PCR. The data was calculated relative to age matched wild type lenses. Gclc enzyme activity was determined by HPLC by monobromobimane fluorescent derivatization. Gclc protein expression was determined by Western-blot. (A). Gclc mRNA was reduced 50% in heterozygous mouse lenses and completely abolished in homozygous mouse lenses (n = 6). (B). Gclc protein level was reduced in heterozygous mouse lenses and abolished in homozygous lenses. Mouse liver protein extract was used as positive control. (C). Gclc activity was mildly reduced in heterozygous mouse lenses and quasi no detectable in homozygous mouse lenses (n = 6). (D). Fresh lenses (n = 6) were snap frozen, thaw at room temperature for 1 min and dissected immediately. The protein was precipitated, and the supernatant was subjected to GSH analysis by glutathione reductase (GR) and β-NADPH enzymatic recycling method. (E). the percentage of GSSG vs. GSH was significantly (p<0.0001) elevated in homozygous mouse lenses vs. wild type/heterozygous lenses. (F). Methionine sulfoxide was significantly (p<0.001) elevated in homozygous vs. wild type/heterozygous lenses, and also significantly increased with age (P<0.05). (G). Glutathione reductase (GR) activity, expressed as unit per milligram of protein, was mildly but significantly (P<0.01) reduced in homozygous lenses vs. wild type, and also significantly reduced with age. (H). Glutathione peroxidase (GPx) activity, expressed as unit per milligram of protein was mildly but significantly reduced in homozygous lens at 9 months old of age (p<0.05). One-Way ANOVA followed by Post-Hoc analysis was used for all comparisons (n = 10, per group, except GSSG/GSH which is 6 per group).
Impact of Suppressed GSH Levels on the Lens: Elevated ROS
The GSSG/GSH ratio, an index of ROS production, was mildly and strongly increased in HET-LESGKO vs. HOM-LEGSKO mice, respectively (Fig. 1E). One of the major protein modifications associated with oxidative stress during human lens aging is methionine sulfoxide (MetSOX), which increases with age and is highly elevated in cataractous lenses, with over 50% of membrane bound protein methionine present in oxidized form , . LC/MS based methionine sulfoxide determination indicated that the HOM-LEGSKO lenses protein bound methionine oxidation was significantly increased compared to heterozygous and wild type control lenses, and it was also elevated with age as measured at 9 months compared to 3 months of age (Fig. 1F). GSH antioxidative cycle enzymes glutathione reductase (GR) and glutathione peroxidase (GPx) activity were mildly but significantly decreased (Fig. 1G&F). Surprisingly, however, we did not find elevation of protein modification by glycation in HOM-LEGSKO mice (Fig.2), such as carboxymethyl-lysine (CML), carboxyethyl-lysine (CEL), methylglyoxal hydroimidazolone-1 (MG-H1), and glyoxal hydroimidazolone-1 (G-H1), which are known to positively correlate with aging in the human lens , . An explanation for this finding is provided in the Discussion.
Carboxymethyl-lysine (CML), carboxyethyl-lysine (CEL), methylglyoxal hydroimidazolone-1 (MG-H1), and glyoxal hydroimidazolone-1 (G-H1) were determined by LC/MS. No significant (n.s) change was observed between WT and LEGSKO lenses. Student’s t test was used for data analysis.
As the 40% reduction of GSH in the cortical region was predicted to increase oxidative stress, we investigated ROS production in living lenses ex vivo. Freshly isolated 6 months old HOM-LEGSKO and age matched control lenses were stained vitally with dihydrorhodamine 123 (DHR), a reactive oxygen species marker, and co-stained DNA with Hoechst 33342 to mark lens cell nuclei. Fluorescence (green) of DHR indicated much stronger ROS also present at cortical region of HOM-LEGSKO lens vs. age matched control lens (Fig.3).
Fresh lenses were stained with both Hoechst 33342 and Dihydrorhodamine 123 (DHR). The Lens anterior was scanned using 10X objective, and 65 µm deep into the cortex and 0.8 µm layer Z-scan was performed and projection image was obtained with same method for both WT and LEGSKO lenses. (A) and (C). Comparison of DNA staining with Hoechst 33342 (blue) of the anterior surface of Wt and LEGSKO lenses. (B) and (D). Comparison of vital staining for ROS fluorescence with DHR stain (green) of the same surface areas.
Impact of Suppressed GSH Levels on Lens Transparency
About 20% of the homozygous mice developed nuclear opacification starting at 3 months of age based on the sensitivity of Slit-lamp detection, which progressed into severe nuclear cataract at 9 months age. In this report, we define opacity as a white area the size of at least 0.3 micrometer diameter. A typical cataract image (Fig. 4A) shows the same lens at 4 and 9 months of age, whereby the nuclear cataract was found to progress from a small opacity at 4 months to severe nuclear cataract at 9 months. The LEGSKO lenses have relative similar size and weight compared to wild type lenses. The GSH level in the lens nucleus was barely detectable and GSH level in the lens cortex dropped over 60% compared to age matched wild type lenses (Table 1).
(A). Representative images of HOM-LEGSKO mouse lens at 4 and 9 months compared with age matched control wild type mouse lens. The same mouse was followed over a period of 9 months and lens images were taken every two months. (B). Slit-lamp images were taken periodically and lens opacity/cataract of any size were recorded for 9 months in homozygous LEGSKO mice vs. age matched wild type mice (n = 30 mice per group). LEGSKO mice developed lens opacities and cataract at much higher rate compared to wild type mice.
The kinetics of the cataract formation was assessed quantitatively using Slit-lamp (Fig. 4B). 50% of HOM-LEGSKO mice had mature cataracts by 4 months compared to age matched wild type mice.
This study shows that genetic suppression of lenticular glutathione synthesis generates phenotypic protein and GSH homeostatic changes that closely resemble those present in the nuclear region of the aging human lens, including cataractogenesis. Several authors have previously contributed to this paradigm by demonstrating that e.g. gamma-glutamyl transpeptidase deficient mice develop nuclear opacities at 1 week secondary to cysteine deficiency , or that treatment with buthionine sulfoxide (BSO) results in lowered GSH levels and cataract in newborn rats  and very young mice . Vice-versa, oxidative stress from hyperbaric oxygen duplicates many changes observed in the aging human lens . Knocking out glutathione peroxidase (GPX-1) in mice leads to cataract formation , whereby changes in lens epithelial cell morphology and DNA breaks were also found under oxidant stress generated by either hydrogen peroxide (H2O2) treatment or GPX-1 null condition . Lens cells behave similarly when glutathione reductase or glutathioredoxin 2 synthesis have been knocked out , . Interestingly, in mouse lenses, free GSH detoxifies more H2O2 (54% to 72%) than GPX-1 (15%) or catalase (30%) .
In old or cataractous human lens there is a GSH gradient from the cortical to the nuclear region . Truscott et al  proposed that a diffusion barrier forms with age, and therefore is an impediment for GSH diffusion. The data from LEGSKO mouse lenses confirm the presence of this gradient with non-detectable GSH in the nucleus of cataractous lenses. These data suggest that a barrier may also form in mouse lenses, and that impaired GSH synthesis is in part responsible for the gradient. Takemoto et al  discovered that crystallins were involved in inter-disulfide cross-linking with membrane, and tight binding of protein to the membrane has been proposed as a potential mechanisms of barrier formation in aged human lenses . In human, lens nucleus enriched crystallins, such as gamma crystallins, have large numbers of free cysteine residues (i.e. 8 cys in human gamma C) compared to alpha crystallin, which only have two cysteine residues. These cysteine residues are maintained in either free form or as intramolecular disulfides to maintain crystallin protein stability in young and normal lenses. However, during aging, with elevated oxidation from reduced GSH level, these cysteine residues are oxidized and form intermolecular disulfide crosslinks. Such transition may impact on crystallin stability, and may cause crystallin unfolding and formation of aggregates with other proteins. Studies will be needed to elucidate the fundamental nature of the protein changes under reduced GSH levels. Because the LEGSKO mouse lenses are too young to accumulate other modifications than those resulting from oxidation, and because these mice are free of diabetes, it will be possible to selectively study the consequences of protein oxidation for protein aggregation.
It has been suggested that maintenance of a threshold of GSH concentration above 1 mM in human lens nucleus was critical for keeping the lens transparent , . This may explain the rapid cataract rate of LEGSKO mice at 9mos, since nuclear GSH is in much lower level i.e. 0.5 mM). In addition, ascorbic acid oxidation may play a key role in crystallin damage in the human lens nucleus when the GSH level drops below a certain threshold. In contrast, the mouse lens has barely detectable ascorbic acid . Furthermore, we found elevated oxidation in the cortical region of LEGSKO lenses compared to wild type lenses, but we did not observe opacity in cortex at 9mos of LEGSKO mice. Thus it remains to be seen if cortical cataract will also form with age.
Another important function of GSH is the detoxification of the oxoaldehydes glyoxal and methylglyoxal, the latter being one of the most important sources of protein damage in aging and cataractous lenses , , . For this reason we expected to find increased levels of carboxymethyl-lysine (CML), carboxyethyl-lysine (CEL) and MG-H1 hydroimidazolone. At first we were surprised that none of these modifications were increased. This may mean there was enough residual glutathione as cofactor of glyoxylase I for the detoxification of these AGE precursors. However, the most likely explanation is that AGE levels are very low because vitamin C is absent in normal and LEGSKO mouse lens (both are ∼100 µM), except in the hSVCT2 transgenic mouse . Indeed previous data from our and other laboratories have unequivocally established ascorbic acid as a major source of these AGEs in the aging lens , , . Breeding experiments between the LEGSKO mouse and the hSVCT2 mouse will confirm the extent to which the GSH/glyoxalase system is important for protection against ascorbic acid derived AGEs. Similarly, exposure of the hSVCT2, LEGSKO and hSVCT2xLEGSKO F1 mouse to UV/VIS light is expected to provide important in vivo information on the role of GSH for protection against photoxidative damage and formation of photosensitizers resulting from tryptophan oxidation.
In summary, lens-specific suppression of GSH synthesis in the LEGSKO mouse, while maintaining all other metabolic body functions intact, resulted in biochemical, biological and cataractous changes mimicking those of age-related human nuclear cataracts. Thus, the LEGSKO mouse is expected to be a useful tool for the development of pharmacological agents that can either restore the antioxidant reserve of the lens or block the distal effects of oxidant stress resulting from GSH deficiency.
Materials and Methods
Creation of Gclc Floxed Mouse
Gclc conditional knockout (Gclcfl/fl) target ES cells with C57BL/6 genetic background were obtained from the European Conditional Knockout Mouse Program (EUCOMM). The Gclcfl/fl exon 2 is flanked by two loxP sites, and the Neo cassette is flanked by two FRT sites. Microinjection of ES cells into C57BL/6J blastocysts was done at the University of Michigan Transgenic Facility, and resulting chimeric male mice were bred with albino female mice to obtain the germ-line. F1 heterozygous Gclcfl/fl mice were bred with mice carrying a ubiquitously expressing Flp knockin mouse (the Jackson lab, stock No. 009086) on a C57BL/6 background to remove the Neo cassette. The resulting Gclcfl/fl mice were cross-bred to generate the homozygous Gclcfl/fl mouse line. The presence of a floxed Gclc allele was identified by PCR using tail DNA with a primer pair (forward primer, 5′-CATGAGGAA CTGAACTGAAGGATTGA-3′; reverse primer, 5′-CAAGGAGGCTCACACATCCCAGAAC-3′), which generated a 310-bp amplicon.
Creation of Lens Conditional Knockout Mouse (Gclcfl/fl/MRL10+/−)
In order to delete Gclc specifically from the lens epithelium and fibers, we crossed the Gclcfl/fl mice with MRL10-Cre mice (FVB background) that express Cre recombinase in lens epithelium and fibers . F1 mice (Gclcfl/wt/MRL10+/−) were backcrossed to Gclcfl/fl mice to generate homozygous lens conditional knockout mice (Gclcfl/fl/MRL10+/−). All the data provide in this paper is based on B6/FVB mixed background. Mice conditionally lacking Gclc in lens (Gclcfl/fl/MRL10+/−), hereafter called LEGSKO, were identified by PCR using both conditional allele (Gclcfl/fl) genotype primer pair and primers pair that amplifies a 190-bp fragment of Cre recombinase coding region (forward primer, 5′-AATTTGCCTGCATTACCGGTCGATGCAACG-3′ and reverse primer 5′-CCATTTCCGGTTATTCAACTTGCACCATGC-3′). Mice were housed under diurnal lighting conditions and allowed free access to food and water. All animals were used in accordance with the guidelines of the Association for Research in Vision and Ophthalmology for the Use of Animals in Ophthalmology and Vision Research, and experimental protocols for this study were approved by the Institutional Animal Care and Use Committee (IACUC) of Case Western Reserve University.
Quantitative Determination of Reduced Glutathione (GSH) and Oxidized Glutathione (GSSG)
Eyes were removed immediately after sacrifice. Lenses were homogenized in 200 µl ice-cold 5% metaphosphoric acid and 0.6% sulfosalicylic acid mixture in 0.1 M potassium phosphate buffer and 5 mM EDTA buffer (pH 7.5). The supernatant was analyzed for GSH and GSSG using glutathione reductase (GR) and β-NADPH enzymatic recycle method followed by colorimetric assay after derivatization with 5,5′-dithio-bis(2-nitrobenzoic acid) (DTNB) as described . Commercially available GSH (G6529, Sigma, St. Louis) and GSSG (49740, Sigma, St. Louis) were used for standard curve calibration.
Lens fibers were subdivided onto cortex and nuclear fraction by a freeze-thawing technique whereby quick freezing at −80°C was followed by thawing at room temperature for 1 min, creating a clear white opacity in nucleus. The cortical and nucleus regions can then be easy separated for GSH and GSSG determination.
γ-Glutamyl Cysteine Ligase Activity Assay
Gcl activity in lens extract was measured using monobromobimane derivatization and HPLC analysis with fluorescence detection as previously reported .
RNA Extraction and Quantitative mRNA Analysis of Gene Expression
Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines  was followed for real time PCR analysis. Eyes were removed immediately after sacrifice. Lenses were collected and quickly frozen with liquid nitrogen and stored at −80°C. Total RNA was prepared from single lens using TRIzol reagent (Invitrogen, Grand Island, NY). RNA concentration was measured with a Nanodrop instrument (2000c, Thermal Sci). Only RNA samples with UV 260 nm/280 nm ratio of 1.9–2.0 and UV 260 nm/230 nm ratio >1.8 were used for subsequent experiments. For real time PCR, total RNA was deoxyribonuclease-treated (Invitrogen, Grand Island, NY) and transcribed to complementary DNA with oligo(dT) or random hexamer primer (Invitrogen, Grand Island, NY) and Moloney murine leukemia virus reverse transcriptase (New England Biolabs, Ipswich, MA ). Real time PCR was performed with the SYBR Green method and an Applied Biosystems instrument (ABI StepOne Plus). Relative expression was calculated using the ΔΔCt method with normalization to constitutive genes as indicated in the figure legends. Specific primer sequences are available on request. All reactions were performed in triplicate. Data analysis was carried out using the cycle threshold values of target gene expression normalized by GAPDH as the internal control.
Lens fiber fractions (cortex or nucleus) were collected in 50 mM potassium phosphate buffer (pH 7.4), homogenized, and centrifuged. Whole protein extracts were further processed for immunoblot analysis and probed against Gclc using an anti-Gclc antibody (1∶2000; Abnova). All data were normalized to the level of GAPDH and compared with age-matched wild type mice.
Lens Protein Enzymatic Digestion for Advanced Glycation Endproduct Analysis
For AGE analysis by LC/MS, 1 mg of lens protein extract was enzymatically digested in Chelex treated phosphate buffer with sequential additions of peptidase (Sigma P7500), protease K, pronase and aminopeptidase M (Roche, IN) as described earlier . Corresponding enzyme blanks were incubated without added protein as a background control. Protein concentration was determined using the ninhydrin assay, as described earlier .
AGEs Determination by LC-MS/MS
Amounts of carboxymethyl-lysine (CML) and carboxyethyl-lysine (CEL), fructose-lysine (FL), methionine sulfoxide (MetSOX), glyoxal immidazolone-1 (G-H1) and methylglyoxal immidazolone-1 (MG-H1) in enzymatically digested samples were measured by electronspray positive ionization-mass spectrometric multiple reaction monitoring (ESI+MRM) with a LC-MS/MS system composed of a 2690 Separation module with a Quattro Ultima triple quadropole mass spectrometry detector (Water-Micromass, Manchester, U.K.) following the previously published procedure , . Analytes released by self-digestion of proteases in assay blanks were subtracted from analytic estimates.
Staining of Freshly Isolated Lenses with Hoechst 33342 and Dihydrorhodamine 123 (DHR)
Fresh isolated lenses were placed in chamber slides and stained with 7.5 µM dihydrorhodamine 123 (DHR) on ice for 45 min, followed by staining with 10 µM Hoechst 33342 for 15 min as described by Wolf et al . The lens in M199 medium was then subjected to confocal image scanning.
Image Analysis Using Confocal Microscope
A laser scanning confocal microscope (Carl Zeiss LSM510 META) was used for whole lens analysis upon vital staining with DNA fluorochrome Hoechst 33342 and ROS marker DHR. The excitation/emission at 405 nm/450 nm was used for Hoechst 3342 and 488 nm/550 nm was used for DHR image. Lens anterior was scanned using 10X objective, and 65 µm deep into the cortex and 0.8 µm layer Z-scan was performed. The image was analyzed with LSM images analysis software from Zeiss.
We thank Christopher Strauch for LC/MC analyses of advanced glycation and oxidation products.
Conceived and designed the experiments: XF VMM. Performed the experiments: XF XL SH BW. Analyzed the data: XF VMM. Contributed reagents/materials/analysis tools: MLR. Wrote the paper: XF VMM.
- 1. Javitt JC, Wang F, West SK (1996) Blindness due to cataract: epidemiology and prevention. Annu Rev Public Health 17: 159–177.
- 2. Klein BE, Klein R, Lee KE, Gangnon RE (2008) Incidence of age-related cataract over a 15-year interval the Beaver Dam Eye Study. Ophthalmology 115: 477–482.
- 3. Panel C (1983) Vision Resarch : a national plan. Washington DC US DHHS:NIH publ: 83–2473.
- 4. Clemons TE, Kurinij N, Sperduto RD (2004) Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. Arch Ophthalmol 122: 716–726.
- 5. Sharma KK, Santhoshkumar P (2009) Lens aging: Effects of crystallins. Biochim Biophys Acta 1790: 1095–1108.
- 6. Heys KR, Friedrich MG, Truscott RJ (2007) Presbyopia and heat: changes associated with aging of the human lens suggest a functional role for the small heat shock protein, alpha-crystallin, in maintaining lens flexibility. Aging Cell 6: 807–815.
- 7. Hains PG, Truscott RJ (2008) Proteomic analysis of the oxidation of cysteine residues in human age-related nuclear cataract lenses. Biochim Biophys Acta 1784: 1959–1964.
- 8. Bhat KS, John A, Reddy PR, Reddy PS, Reddy VN (1991) Effect of pigmentation on glutathione redox cycle antioxidant defense in whole as well as different regions of human cataractous lens. Exp Eye Res 52: 715–721.
- 9. Sweeney MH, Truscott RJ (1998) An impediment to glutathione diffusion in older normal human lenses: a possible precondition for nuclear cataract. Exp Eye Res 67: 587–595.
- 10. Rathbun WB (1984) Lenticular glutathione synthesis: rate-limiting factors in its regulation and decline. Curr Eye Res 3: 101–108.
- 11. Cheng R, Feng Q, Argirov OK, Ortwerth BJ (2004) Structure elucidation of a novel yellow chromophore from human lens protein. J Biol Chem 279: 45441–45449.
- 12. Fan X, Reneker LW, Obrenovich ME, Strauch C, Cheng R, et al. (2006) Vitamin C mediates chemical aging of lens crystallins by the Maillard reaction in a humanized mouse model. Proc Natl Acad Sci U S A 103: 16912–16917.
- 13. Fan X, Sell DR, Zhang J, Nemet I, Theves M, et al. (2010) Anaerobic vs aerobic pathways of carbonyl and oxidant stress in human lens and skin during aging and in diabetes: A comparative analysis. Free Radic Biol Med 49: 847–856.
- 14. Fu S, Dean R, Southan M, Truscott R (1998) The hydroxyl radical in lens nuclear cataractogenesis. J Biol Chem 273: 28603–28609.
- 15. Garner MH, Spector A (1980) Selective oxidation of cysteine and methionine in normal and senile cataractous lenses. Proc Natl Acad Sci U S A 77: 1274–1277.
- 16. Dalton TP, Dieter MZ, Yang Y, Shertzer HG, Nebert DW (2000) Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene: embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous. Biochem Biophys Res Commun 279: 324–329.
- 17. Zhao H, Yang Y, Rizo CM, Overbeek PA, Robinson ML (2004) Insertion of a Pax6 consensus binding site into the alphaA-crystallin promoter acts as a lens epithelial cell enhancer in transgenic mice. Invest Ophthalmol Vis Sci 45: 1930–1939.
- 18. Kannan R, Yi JR, Zlokovic BV, Kaplowitz N (1995) Molecular characterization of a reduced glutathione transporter in the lens. Invest Ophthalmol Vis Sci 36: 1785–1792.
- 19. Hanson SR, Hasan A, Smith DL, Smith JB (2000) The major in vivo modifications of the human water-insoluble lens crystallins are disulfide bonds, deamidation, methionine oxidation and backbone cleavage. Exp Eye Res 71: 195–207.
- 20. Nagaraj RH, Monnier VM (1990) Non-tryptophan fluorescence and high molecular weight protein formation in lens crystallins of rats with chronic galactosemia: prevention by the aldose reductase inhibitor sorbinil. Exp Eye Res 51: 411–418.
- 21. Nagaraj RH, Sell DR, Prabhakaram M, Ortwerth BJ, Monnier VM (1991) High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc Natl Acad Sci U S A 88: 10257–10261.
- 22. Chevez-Barrios P, Wiseman AL, Rojas E, Ou CN, Lieberman MW (2000) Cataract development in gamma-glutamyl transpeptidase-deficient mice. Exp Eye Res 71: 575–582.
- 23. Martensson J, Steinherz R, Jain A, Meister A (1989) Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage. Proc Natl Acad Sci U S A 86: 8727–8731.
- 24. Calvin HI, Medvedovsky C, Worgul BV (1986) Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice. Science 233: 553–555.
- 25. Gosselin ME, Kapustij CJ, Venkateswaran UD, Leverenz VR, Giblin FJ (2007) Raman spectroscopic evidence for nuclear disulfide in isolated lenses of hyperbaric oxygen-treated guinea pigs. Exp Eye Res 84: 493–499.
- 26. Reddy VN, Giblin FJ, Lin LR, Dang L, Unakar NJ, et al. (2001) Glutathione peroxidase-1 deficiency leads to increased nuclear light scattering, membrane damage, and cataract formation in gene-knockout mice. Invest Ophthalmol Vis Sci 42: 3247–3255.
- 27. Reddy VN, Lin LR, Ho YS, Magnenat JL, Ibaraki N, et al. (1997) Peroxide-induced damage in lenses of transgenic mice with deficient and elevated levels of glutathione peroxidase. Ophthalmologica 211: 192–200.
- 28. Giblin FJ, McCready JP, Schrimscher L, Reddy VN (1987) Peroxide-induced effects on lens cation transport following inhibition of glutathione reductase activity in vitro. Exp Eye Res 45: 77–91.
- 29. Wu H, Lin L, Giblin F, Ho YS, Lou MF (2011) Glutaredoxin 2 knockout increases sensitivity to oxidative stress in mouse lens epithelial cells. Free Radic Biol Med.
- 30. Spector A, Ma W, Wang RR, Yang Y, Ho YS (1997) The contribution of GSH peroxidase-1, catalase and GSH to the degradation of H2O2 by the mouse lens. Exp Eye Res 64: 477–485.
- 31. Kodama T, Takemoto L (1988) Characterization of disulfide-linked crystallins associated with human cataractous lens membranes. Invest Ophthalmol Vis Sci 29: 145–149.
- 32. Truscott RJ, Comte-Walters S, Ablonczy Z, Schwacke JH, Berry Y, et al. (2011) Tight binding of proteins to membranes from older human cells. Age (Dordr) 33: 543–554.
- 33. Giblin FJ (2000) Glutathione: a vital lens antioxidant. J Ocul Pharmacol Ther 16: 121–135.
- 34. Ahmed N, Thornalley PJ, Dawczynski J, Franke S, Strobel J, et al. (2003) Methylglyoxal-derived hydroimidazolone advanced glycation end-products of human lens proteins. Invest Ophthalmol Vis Sci 44: 5287–5292.
- 35. Dunn JA, Ahmed MU, Murtiashaw MH, Richardson JM, Walla MD, et al. (1990) Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate. Biochemistry 29: 10964–10970.
- 36. Ortwerth BJ, Bhattacharyya J, Shipova E (2009) Tryptophan metabolites from young human lenses and the photooxidation of ascorbic acid by UVA light. Invest Ophthalmol Vis Sci 50: 3311–3319.
- 37. Rahman I, Kode A, Biswas SK (2006) Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat Protoc 1: 3159–3165.
- 38. Kavanagh TJ (2001) Current Protocols in Toxicology: John Wiley & Sons, Inc.
- 39. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611–622.
- 40. Fan X, Zhang J, Theves M, Strauch C, Nemet I, et al.. (2009) Mechanism of lysine oxidation in human lens crystallins during aging and in diabetes. J Biol Chem.
- 41. Ahmed N, Thornalley PJ (2003) Quantitative screening of protein biomarkers of early glycation, advanced glycation, oxidation and nitrosation in cellular and extracellular proteins by tandem mass spectrometry multiple reaction monitoring. Biochem Soc Trans 31: 1417–1422.
- 42. Pendergrass W, Penn P, Possin D, Wolf N (2005) Accumulation of DNA, nuclear and mitochondrial debris, and ROS at sites of age-related cortical cataract in mice. Invest Ophthalmol Vis Sci 46: 4661–4670.